Showing results (91-100 of 138) with videos related to
Sort By:
Pageof 14
Annals of Neurology|February 22, 2026
Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular DystrophyKarlien Mul, Michael P McDermott, Russell J Butterfield, et al.Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.Journal of Neuromuscular Diseases|February 11, 2020
RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study DesignRichard S Finkel, John W Day, Darryl C De Vivo, et al.Neurology|January 4, 2020
Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trialKaren L Madsen, Astrid E Buch, Bruce H Cohen, et al.Muscle & Nerve|May 19, 2022
Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatabilityPer Widholm, André Ahlgren, Markus Karlsson, et al.Clinical Lung Cancer|October 11, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master ProtocolJ Spicer, N Blais, S Owen, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophyBarry J Byrne, Russell J Butterfield, Perry B Shieh, et al.Oncogene|September 12, 2017
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylationW-F Chiang, T-M Cheng, C-C Chang, et al.Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.Neurology|June 24, 2022
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional AnalysisMichelle L Mellion, Per Widholm, Markus Karlsson, et al.Pageof 14